tirzepatide and osa Which Patients Benefit Most from for Obesity & OSA? Full article: What impact could

Understanding potential adverse events, monitoring strategies, and individual response factors helps inform treatment decisions with your healthcare provi

These findings highlight the importance of targeted therapeutic strategies based on HF phenotypes

A drug approved for diabetes has now been shown to also help patients with diabetes lose on average 10 percent of their body weight, UT Southwestern reports in a landmark international study.

Researchers are currently exploring its effects on glucose regulation, insulin sensitivity, and energy balance in pre-clinical settings.

The convergence of chronic inflammation, mitochondrial dysfunction and altered protein metabolism makes individuals with metabolic diseases particularly vulnerable to sarcopenia